|1.||Wang, C: 1 article (09/2013)|
|2.||Chan, W K K: 1 article (09/2013)|
|3.||Rathore, A P: 1 article (09/2013)|
|4.||Tay, M Y F: 1 article (09/2013)|
|5.||Jans, D A: 1 article (09/2013)|
|6.||Fraser, J E: 1 article (09/2013)|
|7.||Vasudevan, S G: 1 article (09/2013)|
|8.||Moreland, N J: 1 article (09/2013)|
|9.||Verdijk, Pauline: 1 article (08/2013)|
|10.||Boog, Claire J: 1 article (08/2013)|
06/01/2004 - "Compared with the functioning grafts, the failed grafts showed higher prevalence of CAN (60% vs. 16%), lower prevalence of de novo GN (12% vs. 46%), earlier onset of NS (47 vs 65 months post-Tx), higher serum SCr at onset (3.3 vs. 2.0 mg/dL), lower prevalence of remission of NS (5% vs. 48%), and higher proteinuria at follow-up (5.1 vs. 2.5 g/day). "
01/01/2005 - "He developed overt proteinuria 7 months post-transplant and presented with NS 5 months later. "
09/01/2013 - "DENV replication through the virus-encoded nonstructural protein (NS) 5 protein occurs in the infected cell cytoplasm, but NS5 from DENV2 has thus far been shown to localize strongly in the nucleus throughout infection. "
02/01/1995 - "Hepatitis C virus infection was confirmed by a reverse transcription and polymerase chain reaction method for the hepatitis C virus NS-5 region in the sera of alcoholics with various stages of histologically proven liver disease. "
10/01/1995 - "Four days after 100 mg cyclophosphamide/kg, catheterized rats with < 300 PMNs/microL were pretreated with rBPI23 or the irrelevant 22 kDa protein thaumatin [3.3-6.6 mg/kg, i.v. in 0.9% NaCl (NS)] 5 min before graded i.v. infection with 5 x 10(9) or 1 x 10(10) cfu of EC serotype 055:B5 ending at t = 0. "
|3.||Migraine Disorders (Migraine)
02/01/2006 - "To compare the efficacy and tolerability of sumatriptan nasal spray (NS) (5, 20 mg) versus placebo in the acute treatment of migraine in adolescent subjects. "
11/01/2000 - "To compare the efficacy and tolerability of sumatriptan nasal spray (NS; 5 mg, 10 mg, and 20 mg) with placebo for the treatment of acute migraine in adolescents. "
|4.||Body Weight (Weight, Body)
01/01/2013 - "Rats were divided into five experimental groups (control, untreated STZ-diabetic (60 mg/kg B.W., IP), treated STZ-diabetic with hydroalcholic extract of Nigella Sativa (NS) (5 mg/kg B.W, IP), treated STZ-diabetic with hydroalcholic extract of NS (10 mg/kg B.W., IP) and treated STZ-diabetic with hydroalcholic extract of NS (20 mg/kg B.W., IP and 32 days were evaluated to assess its effect on fasting blood glucose (FBG), and in different groups fasting blood glucose (FBG) and body weight (BW) were measured in the particular days (1, 16 and 32). "
08/25/2005 - "Another 40 rats were divided into 5 groups which were administered with indomethacin in the dose of 0 mg/kg (NS), 0 mg/kg (NS), 5, 10 and 20 mg/kg body weight. "
|5.||Interstitial Lung Diseases (Interstitial Lung Disease)
01/01/1993 - "We measured by a radioimmunoassay (RIA) ET-immunoreactive (IR) levels on BALF (BALF-ETIR, pg/ml) from 5 normal subjects (NS), 5 patients with chronic extrapulmonary disease (ED) without signs of lung involvement, 5 patients with allergic bronchial asthma (BA), 10 patients with idiopathic lung fibrosis (ILF) and 9 patients with miscellaneous interstitial lung disease (MILD). "
|3.||RNA (Ribonucleic Acid)
|5.||Lipoprotein Lipase (Diacylglycerol Lipase)
|6.||Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)
|2.||Drug Therapy (Chemotherapy)